sheet_names,cell line,treatment,0,1,2,3,4,5,6,7,8,9,10
GL-CsE,wild-type,placebo,5.51,6.41,5.71,7.94,6.87,7.29,10.04,8.85,8.91,9.68,11.43
GL-bNo,wild-type,placebo,4.47,5.12,4.79,5.86,4.3,5.82,9.94,9.02,8.23,8.37,10.47
GL-JZC,wild-type,activating factor 42,9.1,11.88,15.21,18.41,23.81,25.1,28.75,30.99,36.33,36,41.7
GL-fUg,wild-type,activating factor 42,9.69,12.82,14.78,18.27,21.24,NA,24.25,29.11,32.79,32.69,36.38
GL-jEK,cell-type 101,placebo,5.35,4.01,8.53,9.9,11.66,10.7,13.65,15.98,16.74,18.44,20.21
GL-Hoe,cell-type 101,placebo,5.81,6.58,9.28,10.71,13.67,13.48,15.2,17.65,19.01,19.93,24.47
GL-Rza,cell-type 101,activating factor 42,8.97,11.62,14.87,15.47,17.29,20.78,22.3,24.37,27.44,30.74,33.96
GL-xpo,cell-type 101,activating factor 42,11.49,15.01,17.88,20.17,26.22,31.77,34.43,36.66,39.26,44.18,48.96
